Background: Systemic sclerosis (SSc) is an inflammatory connective tissue disease leading to chronic and progressive fibrosis, typically affecting the skin internal organs. The alteration of both innate adaptive immune responses plays a pivotal role in SSc pathophysiology, although it has not yet been fully elucidated [1]. Recent findings have demonstrated interleukin (IL)-9 overexpression sign...
